Clinical Trial Update: First Line Metastatic Breast Cancer Treatment (ESMERALDA) [Phase 2]

View source ↗

Summary

A Phase 2 trial (ESMERALDA) evaluating first-line treatment for metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED